clinical trial

A researcher using her tablet in a lab
By  Emily Olsen 09:41 am June 22, 2022
Clinical trial software company Florence Healthcare announced Wednesday it had scored $27 million in a Series C-1 round led by Insight Partners. The startup said the investment brings its total raise to $114.1 million. Florence announced an $80 million Series C in May 2021 and a $7.1 million Series B in 2019.  WHAT IT DOES Florence offers tools for managing clinical trials, including remotely...
A piggy bank next to a stethoscope and a pile of coins
By  Emily Olsen 01:08 pm June 2, 2022
Direct primary care startup Hint Health raised $45 million in a funding round led by Banneker Partners and Frist Cressey Ventures, bringing its total raise to $60 million.  Hint offers a platform where providers can enroll patients as members and directly bill for services. The company said the funding will go toward growing its operating system and expanding its primary care provider network....
A smartphone displaying uMotif's app asking, "How are your energy levels today?"
By  Emily Olsen 10:33 am May 26, 2022
Patient data capture and clinical trial tech company uMotif announced Wednesday it had secured $25.5 million from a fund managed by Athyrium Capital Management. The London-based firm raised £5 million in a Series A funding in 2020 and £2.4 million in 2018. WHAT IT DOEs uMotif makes software for gathering patient data for clinical trials and research, including decentralized studies. Its offerings...
A researcher working in a lab
By  Emily Olsen 12:19 pm April 21, 2022
Clinical trial tech company Reify Health raised $220 million in Series D funding, boosting the company's valuation to $4.8 billion. The round was led by Altimeter Capital and Coatue with participation from Dragoneer Investment Group, ICONIQ Growth, Adams Street and Battery Ventures. The Series D comes less than a year after another $220 million raise announced in August. The company also brought...
Doctor talks to patient
By  Laura Lovett 03:04 pm February 8, 2022
YPrime, a cloud-based clinical trial data management tool, announced its plans to buy patient engagement tool Tryl for an undisclosed sum.  Tryl is focused on curbing clinical trial dropout rates by using machine learning and behavioral science to help engage patients and collect data. Patients are able to tap into personalized support throughout the clinical trial. The technology also includes a...
A woman with cancer is consulting her doctor.
By  Emily Olsen 11:38 am February 7, 2022
Trialjectory, a startup that matches cancer patients to clinical trials, announced Monday it had raised $20 million in Series A funding. The round was led by Insight Partners, with participation from JAL Ventures, Contour Venture Partners, Rho Capital and TIA Ventures. WHAT IT DOES The company offers an AI-enabled platform where patients can input information about their type of cancer and...
A person using AeviceMD
By  Adam Ang 11:49 pm October 31, 2021
Singaporean medical technology firm Aevice Health and the National University Health System have announced their partnership to conduct a clinical trial of the former's wearable respiratory monitor. The AI-powered wearable stethoscope AeviceMD remotely detects and records chest sounds at the same time. The sounds are then analysed and translated into heart rate and respiratory rate measurements...
An overview of the digital therapeutic intervention for hypertension
By  Adam Ang 02:53 am September 17, 2021
A landmark clinical trial has found that a new digital therapeutic app for hypertension is effective in reducing the risks of cardiovascular and cerebrovascular diseases. Japanese medical technology startup CureApp collaborated with Jichi Medical University in the Tochigi Prefecture to conduct the third phase of the said clinical trial, which marks the world's first trial of a therapeutic app for...
Scientist working in the laboratory
By  Emily Olsen 11:41 am August 24, 2021
ConcertAI, a healthcare data science and AI company that focuses on oncology, is expanding its partnership with Janssen Research & Development to improve study design and diversify clinical trials. The company, formerly known as Concerto HealthAI, said the collaboration will allow it to expand its data sources, move into disease states at earlier stages and provide more access to new...
The current version of PEAR-004, the company's digital therapeutic for schizophrenia
By  Jonah Comstock 01:59 pm January 13, 2021
Novartis has published results from a clinical trial of Pear Therapeutics' new digital therapeutic for schizophrenia, and the results don't paint a rosy picture. The single-blinded 112-person trial found no difference between the Pear app and a placebo app in any outcome measure, including the primary outcome measure of reducing schizophrenia symptoms. However, the trial did further establish the...